Hemo Organic Ltd

Meeting Details

• Date: 17 October 2026; Time: 4:00 p.m.

Key Agenda Items

• Consider and approve unaudited financial results for Q2 and H1 2026 (ended 30 Sep 2026) Limited Review Report.
• To transact other business as per circulated agenda.

Other Notes

• No additional notes disclosed beyond items on the agenda.

Cessation of Company Secretary and Compliance Officer

• Pratibha Sharma withdraws consent to act as Company Secretary and Compliance Officer with immediate effect.
• The appointment has not taken effect; no material reasons for withdrawal; company to appoint a replacement CS/CO.

Meeting Details

• The meeting date is 3 October 2026.
• The meeting location is the company's registered office.

Key Agenda Items

• The board will consider a funding plan via preferential allotment, private placement, QIP, or rights issue.
• Any other agenda matter to be discussed with the chairman's permission.

Other Notes

• Trading window closed from 29 September 2026 until 48 hours after Sep 2026 results.

HEMO ORGANIC LIMITED — Closure of Trading Window from Thursday, 1st October 2026 till 48 hours after the declaration of Unaudited Financial Results for the Quarter and Half Year ending 30th September, 2026

Capital action

• Allotment approved: 34,00,000 fully paid equity shares on conversion of 34,00,000 warrants.
• Issue price Rs 12.50 per share, including Rs 2.50 premium.
• 75% of issue price received upfront (Rs 9.375 per warrant), total Rs 3,18,75,000.
• Balance 25% payment to be received later, per Annexure A.
• Shares rank pari-passu with existing equity shares.
• Warrants converted into equity shares and allotted on Feb 26, 2026.

Allottees and issuance structure

• Allottees: Vacro Enterprises Private Limited and Qmin Realities Private Limited (Non-Promoter).
• Each allotted 17,00,000 shares on conversion.
• Preferential allotment to Non-Promoter category under ICDR Regulations, 2018.
• Total shares allotted on conversion: 34,00,000.

Post-allotment capital

• Existing paid-up capital: 34,65,900 shares, Rs 3,46,59,000.
• Post-allotment paid-up capital: 68,65,900 shares.
• Capital increased by 34,00,000 shares.

Listing/Regulatory filing

• Company to apply to stock exchange for listing and trading of newly issued shares.
• Convertible warrants converted; allotment completed on 26 February 2026.

Transaction summary

• Target Company: Hemo Organic Limited.
• Disclosing Party: Ketanaben Jasani, Jasani Family Private Trust, Heemaben Makadia; PACs include Ayush D Jasani and Dharmendrabhai Jasani.
• Transaction Type: Acquisition of voting rights in equity shares.
• Pre-Transaction Holding: 2,37,414 shares, 6.84% voting rights.
• Total shares acquired: 4,11,972 (11.88%); Mode: Off-market purchase.
• Post-Transaction Holding: 6,49,386 shares, 18.72% voting rights; diluted 9.44%.
• Date of transaction: 24 September 2026.
• Equity share capital before/after: 34,65,900 shares; Total diluted capital after: 68,65,900 shares.

Transaction details

• Target: Hemo Organic Limited, listed on BSE Limited.
• Acquirer: Dharmendrabhai Becharbhai Jasani; PACs: Jasani Family Private Trust, Ayush Dharmendrabhai Jasani.
• Acquirer not part of promoter/promoter group.
• Stock exchange: BSE Limited.
• Pre-acquisition voting rights: Ayush Dharmendrabhai Jasani held 1,26,073 shares (3.63%).
• Acquisition: 1,11,341 equity shares acquired on 07/09/2026 (3.21%).
• Mode: On-market acquisition.
• Post-acquisition voting rights: Acquirer 1,11,341 (3.21%), PAC 1,26,073 (3.63%), total 2,37,414 (6.84%).
• Post-acquisition diluted: 68,65,900 diluted shares, 3.45%.
• Equity capital before/after: 34,65,900 shares of Rs 10 each.
• Total diluted voting capital after: 68,65,900 shares.

Transaction details

• Target company: Hemo Organic Limited.
• Disclosing party: Dineshbhai Shanabhai Patel (Promoter) and PAC Sonalben Dineshbhai Patel.
• Transaction type: Disposal of 60,000 equity shares via off-market sale.
• Pre-transaction holding: 2,24,968 shares (6.49% voting; 3.28% diluted).
• Post-transaction holding: 1,64,968 shares (4.76% voting; 2.41% diluted).
• Date of transaction: 24/09/2026.
• Share capital before: 34,65,900 shares; after: 68,65,900 shares.
• Total diluted post-transaction capital: 68,65,900 shares.

Key details

• Target Company: HEMO ORGANIC LIMITED.
• Disclosing Party: Sonalben Dineshbhai Patel (Promoter).
• Transaction Type: Disposal of 40,000 equity shares.
• Pre-transaction holding: 47,000 shares (1.36% voting, 0.68% diluted).
• Transaction details: 40,000 shares sold off-market on 23/09/2026 (1.15% voting, 0.58% diluted).
• Post-transaction holding: 7,000 shares (0.21% voting; 0.10% diluted).
• Date of transaction: 23/09/2026.
• Share capital context: Before and after 34,65,900 equity shares; diluted post 68,65,900.

Disposal by promoter – HEMO ORGANIC LIMITED

• Target: HEMO ORGANIC LIMITED; promoter held 5,36,940 voting shares (15.49%).
• Disposal: 3,11,972 equity shares off-market on 23/09/2026.
• Post-holding: 2,24,986 voting shares (6.48%), diluted 3.28%.
• Disclosing party: Dineshbhai Shanabhai Patel (Promoter; promoter group).
• Date: 23/09/2026.
• Capital before/after: 34,65,900 shares; after 68,65,900 diluted.
• Mode: Off-market sale.